4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-015259
Chief Medical Officer sold 5,493 shares at $25.07 ($137,710)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farwell Wildon Chief Medical Officer | 2024-02-12 | Sale 10b5-1 | −5,493 | $25.07 | $137,710 | 163,503 | D |
| Open-market sales · 5,493 sh · avg $25.07 · $137,710 | |||||||
Loading xslF345X05/ownership.xml…